期刊文献+

慢性乙型肝炎患者血清白介素18的临床意义 被引量:1

The Clinical Significance of Srum IL-18 in Patients with Chronic Hepatitis B
暂未订购
导出
摘要 目的探讨IL-18在慢性乙型肝炎(CHB)、肝衰竭中的意义.方法用酶联免疫吸附试验(ELISA)法检测78例CHB患者不同临床类型组血清IL-18水平,与肝功能完全正常的20例健康体检者作对照,同时检测肝功能、乙肝两对半、HBV-DNA、部分病人进行了HbsAg定量测定和PT测定.结果 78例CHB患者血清IL-18水平为(555.46±582.72)ng/mL;健康对照组IL-18水平为(259.0±99.57)ng/mL,经完全随机设计两独立样本比较的秩和检验(P<0.05),2组IL-18水平差异有统计学意义;抗病毒治疗应答组、HbeAg+CHB组、HBeAg-CHB组、肝衰竭组IL-18水平分别为(331.90±228.80)ng/mL、(428.02±244.08)ng/mL、(575.70±339.53)ng/mL、(1299.0±571.40)ng/mL,各组IL-18水平均高于对照组,差异均有统计学意义(z检验,P<0.01),4个临床类型组IL-18水平两两比较,肝衰竭组IL-18水平最高,与其余各组相比,差异均具有统计学意义;HBeAg-CHB组IL-18水平>HbeAg+CHB组>抗病毒治疗组,但差异无统计学意义(P>0.05).高、低病毒载量组IL-18水平分别为(618.64±690.46)ng/mL、(475.60±508.26)ng/mL,差异无统计学意义(P>0.05);HbsAg载量高、低组IL-18水平分别为:(846.40±1175.78)ng/mL)、(701.20±690.46)ng/mL,差异无统计学意义.炎症活动慢性HBV感染组63份病例IL-18与ALT、AST、Tbil相互关系经Spearman等级相关检验,相关系数有统计学意义(P<0.05),呈正相关,其中IL-18与Tbil呈高度正相关.IL-18与HBV-DNA相互关系经Spearman等级相关检验,相关系数无统计学意义(P>0.05).结论 IL-18参与了HBV感染后的免疫反应、肝脏损伤和修复过程;IL-18水平的异常升高可能系肝衰竭发生机制之一;(3)IL-18与肝损伤程度有关,与HBV-DNA、HbsAg载量无明显相关性. Objective To explore the clinical significance of serum IL-18 in the treatment of chronic hepatitis B and liver failure.Methods The serum levels of IL-18 in 78 patients with different clinical types of chronic hepatitis B and 20 healthy subjects with normal liver function were measured with Enzyme-linked immunosorbent assay(ELISA).Meanwhile,the liver function,HBsAg,HBsAb,HBeAg,HBeAb,HBcAb and HBV-DNA of all subjects were measured,and HbsAg levels and PT of some patients were also measured.Results The serum levels of IL-18 in 78 patients with chronic hepatitis B were 555.46 ± 582.72 ng/mL,while in thehealthy control group,the serum levels of IL-18 were(259.0 ± 99.57)ng/mL.By rank sum test which is completely randomized design to compare two independent samples,the serum levels of IL-18 had statistically significant difference between chronic hepatitis B group and healthy control group(P<0.001).The serum levels of IL-18 in Anti-virus group,HbeAg+CHB group,HBeAg-CHB group,liver failure group were(331.90±228.80)ng/mL,(428.02±244.08)ng/mL,(575.70±339.53)ng/mL and(1299.0±571.40)ng/mL,respectively,and in each group the levels of IL-18 were higher than the healthy control group,and the difference was statistically significant(P <0.001).The serum levels of IL-18 in liver failure group were the highest in 4 clinical types of groups,and the difference was statistically significant.The serum levels of IL-18 were: HBeAg-CHB group > HbeAg+CHB group > anti-viral treatment group,but the difference was not statistically significant(P>0.05).The serum levels of IL-18 in high and low viral load groups were(618.64±690.46)ng/mL and(475.60±508.26)ng/mL,respectively,and there was no statistically significant difference(P>0.05).The serum levels of IL-18 of the load of HbsAg in the high and low groups were(846.40±1175.78)and(701.20±690.46)ng/mL,respectively,and there was no statistically significant difference(P>0.05).The relationships between IL-18 and ALT,AST,and Tbil were analyzed by Spearman rank correlation test and correlation coefficient was statistically significant(P<0.05)in 63 cases with the inflammatory activity of chronic HBV infection,indicating there was a positive correlation between IL-18 and ALT,AST,and Tbil.IL-18 is positively correlated with Tbil in a high degree.The relationship between IL-18 and HBV-DNA was tested by the Spearman rank correlation,the correlation coefficient was not statistically significant(P>0.05).Conclusions IL-18 is involved in the immune response,liver injury and reconditioning to HBV infection;IL-18 may be one of the reasons of hepatic failure;Serum levels of IL-18 are related to the degree of liver injury,and have no significant correlation with the loads of HBV-DNA and HbsAg.
出处 《昆明医学院学报》 2012年第3期57-61,75,共6页 Journal of Kunming Medical College
基金 云南省卫生科技基金资助项目(WSK2009)
关键词 乙型肝炎 IL-18 临床类型 肝损伤 Hepatitis B IL-18 Clinical types Liver injury
  • 相关文献

参考文献9

二级参考文献28

  • 1Jing You Lin Zhuang Bao Zhang Tang Wei Bo Yang Su Ying Ding Wu Li Rong Xue Wu Hong Li Zhang Yan Mei Zhang Shao Ming Yan Lu Zhang ~1Department of Infectious Diseases,The First Affiliated Hospital of Kunming Medical College,Kunming 650032,Yunnan Province,China ~2Departrnent of Hepatology,Kunming Third Municipal People’s Hospital,Kunming 650041,Yunnan Province,China.A randomized controlled clinical trial on the treatment of Thymosin-a1 versus interferon-α in patients with hepatitis B[J].World Journal of Gastroenterology,2001,7(3):411-414. 被引量:48
  • 2覃小敏,宁琴.重型肝炎发病的分子机制研究进展[J].国外医学(流行病学.传染病学分册),2004,31(3):150-152. 被引量:21
  • 3曹雪涛.细胞因子研究的现状与发展趋势[J].中国肿瘤生物治疗杂志,1995,2(3):175-181. 被引量:25
  • 4Peng-Yuan Zheng,Dong-Yun Zhang,Gao-Feng Lu,Ping-Chang Yang,Yuan-Ming Qi,Bai-Sheng Wang.Effects of lamivudine on the function of dendritic cells derived from patients with chronic hepatitis B virus infection[J].World Journal of Gastroenterology,2007,13(34):4641-4645. 被引量:9
  • 5Rota C, Bergamini S, Daneri F, et al. N-Acetylcysteine negatively modulates nitric oxide production in endotoxin-treated rats through inhibition of NF-kappaB activation. Antioxide Redox Signal,2002, 4:221-226.
  • 6Kim YM, Talanian RV, Li J, et al. Nitric oxide prevents ILlbeta and IFN-gamma-inducing factor IL-18 release from macrophages by inhibiting caspase-1 (IL-1 beta-converting enzyme). J Immunol, 1998, 161:4122-4128.
  • 7Hui TT, Mizuguchi T, Sugiyama N, et al. Immediate early genes and p21 regulation in liver of rats with acute hepatic failure. Am J Surg, 2002,183:457-463.
  • 8Shibata M, Hirota M, Ogawa M. Hepatic injury induced by interleukin-18 administration: importance of preceding priming effect. J Immunother, 2002, 25 Supp1 1 :S72-74.
  • 9Hirota M, Shibata M, Ogawa M. Increased concentrations of plasma interleukin-18 in patients with hepatic failure 1 week after surgery. J Immunother, 2002, 25 Supple 1: S75-77.
  • 10NAKANISHI K.Regulation of Th1 and Th2 immune responses by IL 18[J].Kekkaku,2002,77(2):87-93.

共引文献31

同被引文献20

  • 1谭友文,吴建成.IL-18及IL-18抗体对刀豆蛋白A所致急性肝损伤的作用[J].江苏医药,2007,33(4):392-393. 被引量:3
  • 2Manea I,Manea CN,Miron N. Immunological aspects in viral hepatitis B and C infection[J].Roumanian Archives of Microbiology and Immunology,2011.97-100.
  • 3Chen Z,Cao J,Liao X. Plasmids enriched with CpG notifs activate human peripheral blood mononuclear cells in vitro and enhance Th-1 immune responses to hepatitis B surface antigen in mice[J].Viral Immunology,2011.199-209.
  • 4Chia CS,Ban K,Ithnin H. Expression of interleukin-18,interferon-gamma and interleukin-10 in hepatocellular carcinoma[J].Immunology letters,2002.163-172.
  • 5Tschoeke SK,Oberholzer A,Moldawer LL. Interleukin-18:a novel prognostic cytokine in bacteria-induced sepsis[J].Critical Care Medicine,2006.1225-1233.
  • 6Lee TB,Min YD,Lim SC. Fas(Apo-l/CD95) and Fas ligand interaction between gastric cancer cells and immue cells[J].Journal of Gastroenterology and Hepatology,2002.32-38.
  • 7Shibata M,Hirota M,Nozawa F. Increased concentration of plasma IL-18 in patient with hepatic dysfunction after keratectomy[J].Cytokine,2000.1256-1263.
  • 8Zhang Z,Zhang S,Zou Z. Hypercytolytie activity of hepatic natural killer cells eorrelates with liver injury in chronic hepatitis B patients[J].Hepatology,2011.73-85.
  • 9Kao JH. Diagnosis of hepatitis B virus infection through serological and virological markers[J].Expert Review of Gastroenterology and Hepatology,2008.553-562.
  • 10Post A,Nagendra S. Reactivation of hepatitis B:pathogenesis and clinical implications[J].Current Infectious Disease Reports,2009.113-119.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部